Furthermore, we suggest stratification strategies for future development, where NSCLC subtype 4 classification, STK11/KEAP1 mutations, or neuroendocrine lineage would be negative predictive factors. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.